GCC: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2024

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in GCC

The GCC prophylactic medicaments containing insulin market expanded slightly to $X in 2022, surging by 3.2% against the previous year. In general, consumption, however, enjoyed strong growth. Over the period under review, the market reached the peak level at $X in 2017; however, from 2018 to 2022, consumption stood at a somewhat lower figure.

Production of Medicaments Containing Insulin But Not Antibiotics In Measured Doses in GCC

In value terms, prophylactic medicaments containing insulin production expanded sharply to $X in 2022 estimated in export price. Overall, production, however, saw a buoyant expansion. The growth pace was the most rapid in 2014 when the production volume increased by 46%. Over the period under review, production hit record highs at $X in 2017; however, from 2018 to 2022, production stood at a somewhat lower figure.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports in GCC

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses exported in GCC skyrocketed to X tons, with an increase of 331% compared with 2021 figures. In general, exports saw a significant expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, prophylactic medicaments containing insulin exports expanded to $X in 2022. Over the period under review, exports continue to indicate a strong expansion. The most prominent rate of growth was recorded in 2017 with an increase of 241% against the previous year. The level of export peaked at $X in 2020; however, from 2021 to 2022, the exports remained at a lower figure.

Exports by Country

The United Arab Emirates dominates exports structure, amounting to X tons, which was approx. 97% of total exports in 2022. Bahrain (X tons) followed a long way behind the leaders.

Exports from the United Arab Emirates increased at an average annual rate of +31.6% from 2012 to 2022. At the same time, Bahrain (+79.9%) displayed positive paces of growth. Moreover, Bahrain emerged as the fastest-growing exporter exported in GCC, with a CAGR of +79.9% from 2012-2022. Bahrain (+2.6 p.p.) significantly strengthened its position in terms of the total exports, while the United Arab Emirates saw its share reduced by -2.3% from 2012 to 2022, respectively.

In value terms, the United Arab Emirates ($X) remains the largest prophylactic medicaments containing insulin supplier in GCC, comprising 90% of total exports. The second position in the ranking was held by Bahrain ($X), with a 9.9% share of total exports.

In the United Arab Emirates, prophylactic medicaments containing insulin exports increased at an average annual rate of +15.3% over the period from 2012-2022.

Export Prices by Country

In 2022, the export price in GCC amounted to $X per ton, shrinking by -75.7% against the previous year. Over the period under review, the export price showed a abrupt downturn. The pace of growth appeared the most rapid in 2013 when the export price increased by 86% against the previous year. Over the period under review, the export prices attained the peak figure at $X per ton in 2017; however, from 2018 to 2022, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Bahrain ($X per ton), while the United Arab Emirates amounted to $X per ton.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Bahrain (+10.0%).

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports in GCC

In 2022, the amount of medicaments containing insulin but not antibiotics in measured doses imported in GCC expanded significantly to X tons, surging by 11% on the previous year. In general, imports continue to indicate prominent growth. The pace of growth appeared the most rapid in 2014 with an increase of 72% against the previous year. Over the period under review, imports reached the maximum at X tons in 2020; however, from 2021 to 2022, imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports expanded markedly to $X in 2022. Over the period under review, imports saw a buoyant increase. The pace of growth appeared the most rapid in 2017 when imports increased by 43%. The level of import peaked at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

Saudi Arabia prevails in imports structure, resulting at X tons, which was approx. 71% of total imports in 2022. The United Arab Emirates (X tons) ranks second in terms of the total imports with a 9.8% share, followed by Oman (9.2%) and Kuwait (5.5%). Qatar (X tons) followed a long way behind the leaders.

Imports into Saudi Arabia increased at an average annual rate of +13.7% from 2012 to 2022. At the same time, Kuwait (+27.0%), Oman (+12.0%), the United Arab Emirates (+7.2%) and Qatar (+4.7%) displayed positive paces of growth. Moreover, Kuwait emerged as the fastest-growing importer imported in GCC, with a CAGR of +27.0% from 2012-2022. While the share of Saudi Arabia (+8.6 p.p.) and Kuwait (+3.9 p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Qatar (-2.9 p.p.) and the United Arab Emirates (-5.8 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Saudi Arabia ($X) constitutes the largest market for imported medicaments containing insulin but not antibiotics in measured doses in GCC, comprising 60% of total imports. The second position in the ranking was held by the United Arab Emirates ($X), with a 25% share of total imports. It was followed by Oman, with a 5.8% share.

In Saudi Arabia, prophylactic medicaments containing insulin imports increased at an average annual rate of +13.6% over the period from 2012-2022. In the other countries, the average annual rates were as follows: the United Arab Emirates (+9.0% per year) and Oman (+16.6% per year).

Import Prices by Country

In 2022, the import price in GCC amounted to $X per ton, with an increase of 3.7% against the previous year. Over the period under review, the import price recorded a relatively flat trend pattern. The growth pace was the most rapid in 2019 when the import price increased by 35%. As a result, import price attained the peak level of $X per ton. From 2020 to 2022, the import prices remained at a lower figure.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was the United Arab Emirates ($X per ton), while Oman ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Kuwait (+4.3%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform